|
| FDA Approves MIXJECT, A Convenient, Easy-To-Use Drug Delivery System For Watson Pharmaceutical's TRELSTAR DEPOT And ... |
5 May 08, 14:10 |
|
| Watson Pharmaceuticals, Inc. WPI, a leading specialty pharmaceutical company, announced recently that the U.S. Food and Drug Administration has approved MIXJECT, the new delivery system for TRELSTAR (triptorelin pamoate for injectable suspension), a palliative treatment for advanced prostate cancer. |
| more |
|
